PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy

Hong Lou; David Langan; Nick Syracuse; Elisabeth A. Murphy; Sojung Kim; Emma Robinson; Nicole M. Rossi; Yi Xie; Sonam Tulsyan; Tawnjerae Joe; Isabel Rodriguez; Nina Rao; Matthew R. Oberley; Mathias Oelke; Michael Dean

doi:https://doi.org/10.1016/j.neo.2026.101305

PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy

Identifier:nobleid.org/w1/20260418/78D5A6AD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/78D5A6AD.svg?ark=w1%2F20260418%2F78D5A6AD)](https://nobleid.org/work/w1/20260418/78D5A6AD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy

Identifier:nobleid.org/w1/20260418/78D5A6AD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/78D5A6AD.svg?ark=w1%2F20260418%2F78D5A6AD)](https://nobleid.org/work/w1/20260418/78D5A6AD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work